LORAZEPAM - A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY OF A NEW ANTIEMETIC IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY AND PROCHLORPERAZINE

被引：60

作者：

BISHOP, JF ^{[1
]}

OLVER, IN ^{[1
]}

WOLF, MM ^{[1
]}

MATTHEWS, JP ^{[1
]}

LONG, M ^{[1
]}

BINGHAM, J ^{[1
]}

HILLCOAT, BL ^{[1
]}

COOPER, IA ^{[1
]}

机构：

[1] PETER MACCALLUM HOSP,MELBOURNE,AUSTRALIA

来源：

关键词：

D O I：

10.1200/JCO.1984.2.6.691

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：691 / 695

页数：5

共 11 条

[1] PHARMACOKINETICS OF 2 LORAZEPAM FORMULATIONS, ORAL AND SUBLINGUAL, AFTER MULTIPLE DOSES
CAILLE, G
SPENARD, J
LACASSE, Y
BRENNAN, J
[J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (01) : 31 - 42
[2] COMPARISON OF THE ACTIONS OF DIAZEPAM AND LORAZEPAM
DUNDEE, JW
MCGOWAN, WAW
LILBURN, JK
MCKAY, AC
HEGARTY, JE
[J]. BRITISH JOURNAL OF ANAESTHESIA, 1979, 51 (05) : 439 - 446
[3] ELLIOTT HW, 1971, CLIN PHARMACOL THER, V12, P468
[4] LORAZEPAM AS AN ADJUNCT TO ANTI-EMETIC THERAPY WITH HALOPERIDOL IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY
FRIEDLANDER, ML
KEARSLEY, JH
SIMS, K
COATES, A
HEDLEY, D
RAGHAVAN, D
FOX, RM
TATTERSALL, MHN
[J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1983, 13 (01): : 53 - 56
[5] FRYTAK S, 1981, JAMA, V245, P383
[6] LASZLO J, 1983, P AN M AM SOC CLIN, V2, P95
[7] MEUR MN, 1983, P AM SOC CLIN ONCOL, V2, P88
[8] PEROUTKA, 1982, LANCET, V1, P658
[9] MEASURING THE QUALITY OF LIFE OF CANCER-PATIENTS - A CONCISE QL-INDEX FOR USE BY PHYSICIANS
SPITZER, WO
DOBSON, AJ
HALL, J
CHESTERMAN, E
LEVI, J
SHEPHERD, R
BATTISTA, RN
CATCHLOVE, BR
[J]. JOURNAL OF CHRONIC DISEASES, 1981, 34 (12): : 585 - 597
[10] LORAZEPAM AS NIGHT SEDATION AND PREMEDICATION - COMPARISON WITH DIAZEPAM
STUDD, C
ELTRINGHAM, RJ
[J]. ANAESTHESIA, 1980, 35 (01) : 60 - 64